Newark, DE, United States of America

Dilip P Modi

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Dilip P Modi

Introduction

Dilip P Modi is a notable inventor based in Newark, DE (US), recognized for his contributions to pharmaceutical innovations. He holds a total of 4 patents, showcasing his expertise in the field of drug formulation and delivery systems.

Latest Patents

Among his latest patents, one significant invention is the development of sustained release dosage forms for a JAK1 inhibitor. This invention relates to sustained release dosage forms comprising {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, along with doses and methods related to this formulation.

Career Highlights

Dilip has worked with prominent companies in the pharmaceutical sector, including Incyte Corporation and Incyte Holdings Corporation. His work has significantly impacted the development of innovative drug delivery systems.

Collaborations

Throughout his career, Dilip has collaborated with esteemed colleagues such as Krishnaswamy Yeleswaram and Bhavnish Parikh, contributing to various projects and advancements in the field.

Conclusion

Dilip P Modi's contributions to pharmaceutical innovations, particularly in sustained release dosage forms, highlight his role as a significant inventor in the industry. His work continues to influence the development of effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…